13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

11 trials found

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-001224-22-IT (EUCTR)	24/09/2019	20/01/2021	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multipl ...	Multiple Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10067063;Term: Progressive rel ...	Trade Name: N/A Product Name: Opicinumab Product Code: [BIIB033] INN or Proposed INN: Opicinumab	BIOGEN IDEC RESEARCH LIMITED	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	Sweden;United States;Czechia;Spain;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech Repu ...
2	EUCTR2017-001224-22-PL (EUCTR)	08/02/2018	15/11/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multipl ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Canada;Pol ...
3	EUCTR2017-001224-22-BE (EUCTR)	02/02/2018	08/09/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multipl ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Canada;Bel ...
4	EUCTR2017-001224-22-DE (EUCTR)	23/01/2018	28/07/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension ...	Multiple Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Czechia;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Ca ...
5	EUCTR2017-001224-22-NL (EUCTR)	11/01/2018	12/09/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension ...	Multiple Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Canada;Bel ...
6	EUCTR2017-001224-22-GB (EUCTR)	28/12/2017	12/07/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Spain;Israel;Italy;United Kingdom;Switzerland;France;Czech Republic;Hungary;Canada;Pol ...
7	EUCTR2017-001224-22-CZ (EUCTR)	19/12/2017	14/08/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Canada;Bel ...
8	EUCTR2017-001224-22-ES (EUCTR)	24/11/2017	18/09/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multipl ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Hungary;Canada;Bel ...
9	NCT03222973 (ClinicalTrials.gov)	November 14, 2017	17/7/2017	Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMT ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension ...	Multiple Sclerosis	Drug: BIIB033 (opicinumab);Drug: Placebo	Biogen	NULL	Terminated	18 Years	58 Years	All	263	Phase 2	Netherlands;Poland;Spain;Switzerland;United Kingdom;United States;Australia;Belgium;Canada;Czechia;F ...
10	EUCTR2017-001224-22-HU (EUCTR)	31/10/2017	01/09/2017	Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multipl ...	Multiple Sclerosis MedDRA version: 20.0;Level: PT;Classification code 10067063;Term: Progressive rel ...	Product Name: Opicinumab Product Code: BIIB033 INN or Proposed INN: Opicinumab Other descriptive name: ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	240	Phase 2	United States;Spain;Israel;United Kingdom;Switzerland;Italy;France;Hungary;Czech Republic;Canada;Bel ...

First Previous1 2Next Last